Copper, zinc and magnesium levels in fibrocalculous pancreatic diabetes

Summary:

Alterations in trace elements and mineral homeostasis have been documented both in insulin-dependent diabetes mellitus and non-insulin dependent diabetes mellitus. No data are available about trace elements in fibrocalculous pancreatic diabetes, a unique form of secondary diabetes mellitus. This study evaluated the plasma concentrations of copper, zinc and magnesium in this form of diabetes. Twenty-five patients (9 men and 16 women) with fibrocalculous pancreatic diabetes and 25 healthy non-diabetic subjects (16 men and 9 women) were studied. Patients with overt nephropathy were excluded. Plasma copper, zinc, and magnesium levels were analyzed using a GBC 902 double beam absorption spectrophotometer. The effect of glycemic control, microalbuminuria, sex and modality of treatment received on the plasma levels of copper, zinc and magnesium was assessed. Results of the study revealed that plasma copper, zinc, and magnesium levels were comparable between patients with fibrocalculous pancreatic diabetes and control subjects. Plasma copper levels were significantly higher in patients with controlled diabetes (16.15 ± 0.67 μmol L^-1) as compared to those with uncontrolled diabetes (13.75 ± 0.61 μmol L^-1) and healthy controls (13.91 ± 0.55 μmol L^-1). This merits further investigation. Microalbuminuria, modality of treatment received and sex did not influence the levels of these elements in fibrocalculous pancreatic diabetes.

Fibrocalculous pancreatic diabetes - copper - zinc - magnesium

References

• 1 Car N, Car A, Granic M, Skrabalo Z, Moncilovic B. Zinc and copper in the serum of diabetic patients.  Biological Trace Element Research. 32 325-329 1992; 
• 2 Corica F, Allegra A, Giacobbe M S, Ceruso D. The role of magnesium in glucose homeostasis: therapeutic implications.  Clinical Therapeutica. 143 45-55 1993; 
• 3 Isbir T, Tamer L, Taylor A, Isbir M. Zinc, copper and magnesium status in insulin-dependent diabetes.  Diabetes Research. 26 41-45 1994; 
• 4 Kinlaw W B, Levine A S, Morley J E, Silvis S E, McClain C J. Abnormal zinc metabolism in type II diabetes mellitus.  Am J Med. 75 273-277 1983; 
• 5 Legrand C, Okitolonda W, Pottier A M, Lederer J, Henquin J C. Glucose homeostasis in magnesium-deficient rats.  Metabolism. 36 160-164 1987; 
• 6 Mohan V, Premalatha G. Malnutrition-related diabetes mellitus. In: Pickup J, Williams G, eds. Textbook of Diabetes, 2nd edn London: Blackwell Science 1997
• 7 Mooradian A D, Morley J E. Micronutrient status in diabetes mellitus.  Am J Clin Nutr. 45 877-895 1987; 
• 8 Raz I, Havivi E. Trace elements in blood cells of diabetic subjects.  Diabetes Research. 10 21-24 1989; 
• 9 Schlienger J L, Grunenberger F, Maier E A, Simon C, Chabrier G, Leroy M I. Disorders of plasma trace elements in diabetes, relation to blood glucose equilibrium.  Presse Med. 17 1076-1079 1988; 
• 10 Terres-Martos C, Navarro-Alarcon M, Martin-Lagos F, Lopez-G de La Serrana H, Perez-Valero V, Lopez-Martinez M C. Serum zinc and copper concentrations and Cu/Zn ratio in patients with hepatopathies or diabetes.  Journal of Trace Elements in Medicine and Biology. 12 44-49 1998; 
• 11 Williams B, Lehman P: . In: European Fructosamine Workshop Vienna 1989, Henricks HR, ed.  Wien Klin Wschr 102 ((Suppl 3)) 9 1990; 
• 12 Zargar A H, Laway B A, Masoodi S R, Shah N A, Shah J A. Fibrocalculous pancreatic diabetes from the Kashmir valley.  Ann Saudi Med. 16 144-147 1996; 
• 13 Zargar A H, Shah N A, Masoodi S R, Laway B A, Dar F A, Khan A R, Sofi F A, Wani A I. Copper, zinc and magnesium levels in non-insulin dependent diabetes mellitus.  Postgrad Med J. 74 665-668 1998;